Baseline characteristics of an incident haemodialysis population in Spain: Results from ANSWER - A multicentre, prospective, observational cohort study

Nephrology Dialysis Transplantation

Volumn 24, Issue 2, 2009, Pages 578-588

  Pérez García, Rafael ^a   Martín Malo, Alejandro ^b   Fort, Joan ^c   Cuevas, Xavier ^d   Lladós, Fina ^e   Lozano, Javier ^e   García, Fernando ^f  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d Brain   (Spain)

^e Amgen SA   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Cardiovascular; Haemodialysis; Malnutrition; Risk factors; Vascular access

Indexed keywords

FERRITIN; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD CHEMISTRY; CARDIOVASCULAR DISEASE; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KARNOFSKY PERFORMANCE STATUS; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; PATIENT REFERRAL; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SPAIN; VASCULAR ACCESS;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CATHETERS, INDWELLING; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RENAL DIALYSIS; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 58449094054     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn464     Document Type: Article

References (63)

1. Pozzoni P, Del Vecchio L, Pontoriero G et al. Long-term outcome in hemodialysis: morbidity and mortality. J Nephrol 2004; 17: S87-S95
2. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(Suppl 12): 16-23
3. Hegarty J, Foley RN. Anaemia, renal insufficiency and cardiovascular outcome. Nephrol Dial Transplant 2001; 16(Suppl 1): 102-104
4. Goodkin DA, Mapes DL, Held PJ. The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients? Semin Dial 2001; 14: 157-159
5. Trespalacios FC, Taylor AJ, Agodoa LY et al. Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int 2002; 62: 1799-1805
6. Stack AG, Bloembergen WE. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol 2001; 12: 1516-1523
7. Merkus MP, Jager KJ, Dekker FW et al. The NECOSAD Study Group. Predictors of poor outcome in chronic dialysis patients: the Netherlands Cooperative Study on the Adequacy of Dialysis. Am J Kidney Dis 2000; 35: 69-79
8. Noordzij M, Korevaar JC, Bos WJ et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant 2006; 21: 2513-2520
9. Jungers P, Choukroun G, Robino C et al. Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998. Nephrol Dial Transplant 2000; 15: 2000-2006
10. Pernod G, Bosson JL, Golshayan D et al. The Diamant Alpin Dialysis Cohort Study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients. J Nephrol 2004; 17: 66-75
11. Pernod G, Bosson JL, Golshayan D et al. Phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohort. Kidney Int 2006; 69: 1424-1430
12. Villar E, Remontet L, Labeeuw M et al. Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 2007; 18: 2125-2134
13. Di Benedetto A, Marcelli D, D'Andrea A et al. Risk factors and underlying cardiovascular diseases in incident ESRD patients. J Nephrol 2005; 18: 592-598
14. Locatelli F, Marcelli D, Conte F et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol 2001; 12: 2411-2417
15. Honda H, Qureshi AR, Heimbürger O et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148
16. López Revuelta K, Saracho R, García López F et al. Informe de diálisis y trasplante año 2001 de la Sociedad Española de Nefrología y Registros Autonómicos. Nefrología 2004; 24: 21-33
17. Altisent R, Córdoba R, Martin JM. Criterios operativos para le prevención del alcoholismo. Med Clin (Barc) 1992; 99: 584-588
18. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-383
19. Charlson M, Szatrowski TP, Peterson J et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251
20. Ware J, Snow KK, Kosinski M et al. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993
21. Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clin (Barc) 1995; 104: 771-776
22. Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995; 2: 295-304
23. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration equation from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
24. National Kidney Foundation (NKF) K/DOQI Guidelines. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S7-S201
25. Locatelli F, Aljama P, Bárány P et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19(Suppl 2): ii1-ii47
26. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170
27. Sociedad Española deNefrología-Grupo deRegistros deEnfermos Renales. Informe de Díalisis y Trasplante, 2003; SEN 2004
28. Sociedad Española deNefrología-Grupo deRegistros deEnfermos Renales. Informe de Diálisis y Trasplante, 2004; SEN 2005
29. Miskulin DC, Meyer KB, Athienites NV et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 2002; 39: 324-336
30. Ishani A, Collins AJ, Herzog CA et al. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 2005; 68: 311-318
31. Li Z, Lacson E Jr, Lowrie EG et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 2006; 48: 606-615
32. Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007; 72: 1004-1013
33. Rayner HC, Pisoni RL, Bommer J et al. Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 108-120
34. Portolés J, López-Gómez JM, Aljama P. Riesgo cardiovascular en hemodiálisis en España: prevalencia, pautas de actuación y objetivos (estudio MAR). Nefrologia 2005; 25: 297-306
35. United States Renal Data System. 2006 Annual Data Report. National Institutes of Health, National Institute of Diabetes & Digestive & Kidney Diseases, Division of Kidney, Urologic, & Hematologic Diseases, 2006
36. Cruz PM, Piera L, Bragg-Gresham JL et al. Results of the international hemodialysis study DOPPS in Spain and Europe. Nefrologia 2003; 23: 437-443
37. Hecking E, Bragg-Gresham JL, Rayner HC et al. Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 100-107
38. Valdés C, García-Mendoza M, Rebollo P et al. Mental health at the third month of haemodialysis as a predictor of short-term survival. Nephrol Dial Transplant 2006; 21: 3223-3230
39. McKane W, Chandna SM, Tattersall JE et al. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 2002; 61: 256-265
40. Chandna SM, Schulz J, Lawrence C et al. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ 1999; 318: 217-223
41. Kimmel PL, Peterson RA, Weihs KL et al. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis. J Am Soc Nephrol 1996; 7: 2152-2159
42. Sanz Guajardo D, Orte L, Gómez-Campderá F et al. INESIR Group. Calidad de vida en los pacientes con insuficiencia renal cronica. Influencia de la intervencion precoz del nefrologo y de la consulta predialisis. Nefrologia 2006; 26(Suppl 3): 56-65
43. López Revuelta K, García López FJ, de Alvaro Moreno F et al. Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end-stage renal disease (CALVIDIA Study). Nephrol Dial Transplant 2004; 19: 2347-2353
44. Pisoni RL, Young EW, Dykstra DM et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 2002; 61: 305-316
45. Rodríguez Hernández JA, López Pedret J, Piera L. El acceso vascular en España: análisis de su distribución, morbilidad y sistemas de monitorización. Nefrologia 2001; 21: 45-51
46. Rodríguez JA, Armadans L, Ferrer E et al. The function of permanent vascular access. Nephrol Dial Transplant 2000; 15: 402-408
47. Rodríguez JA, López J, Piera L. El acceso vascular en España: análisis de su distribución, morbilidad y sistemas de monitorización. Nefrología 2001; 21: 45-51
48. RMRC: Informe Estadistic 2000. Servei Català de la Salut. Departament de Sanitat i Seguretat Social. Barcelona, 2001
49. Valderrábano F, Hörl WH, Macdougall IC et al. PRE-dialysis survey on anaemia management. Nephrol Dial Transplant 2003; 18: 89-100
50. Gómez-Campderá FJ, Orte L, Aguilar MD et al. INESIR Group. Situación clínica del paciente en el momento de iniciar diálisis. Estudio INESIR. Nefrologia 2006; 26(Suppl 3): 12-18
51. Rayner HC, Besarab A, Brown WW et al. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis 2004a; 44(Suppl 2): S22-S26
52. Lorenzo V, Martn M, Rufino M et al. Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study. Am J Kidney Dis 2004; 43: 999-1007
53. Ifudu O, Dawood M, Homel P et al. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 1996; 28: 841-845
54. Roubicek C, Brunet P, Huiart L et al. Timing of nephrology referral: influence on mortality and morbidity. Am J Kidney Dis 2000; 36: 35-41
55. Castellano I, Gallego S, Labrador PJ et al. Comienzo de tratamiento renal sustitutivo en la provincia de Caceres. Nefrologia 2006; 26: 379-381
56. National Kidney Foundation. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000. Am J Kidney Dis 2001; 37(Suppl 1): S7-S64
57. Korevaar JC, Jansen MA, Dekker FW et al. Netherlands Cooperative Study on the Adequacy of Dialysis Study Group. When to initiate dialysis: effect of proposed US guidelines on survival. Lancet 2001; 358: 1046-1050
58. Locatelli F, Pisoni RL, Combe C et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 121-132
59. Longenecker JC, Coresh J, Powe NR et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 2002; 13: 1918-1927
60. Manresa JM, Zamora A, Tomás M et al. Relationship of classical and non-classical risk factors with genetic variants relevant to coronary heart disease. Eur J Cardiovasc Prev Rehabil 2006; 13: 738-744
61. Bostom AG, Shemin D, Verhoef P et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol 1997; 17: 2554-2558
62. Young EW, Akiba T, Albert JM et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44(Suppl 2): 34-38
63. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 2007; 18: 2644-2648